Ke Jin

No ORCID on file · 2 papers in corpus
review 2026
Translational cancer research ·doi:10.21037/tcr-2026-1-0258

BACKGROUND AND OBJECTIVE: Poly(ADP-ribose) polymerase inhibitors (PARPis) have fundamentally changed the treatment paradigm for patients with ovarian cancer, especially in tumors with homologous recombination deficiency (HRD). However, acqu…

review 2026
Redox biology ·doi:10.1016/j.redox.2026.104051

Cannabidiol (CBD), a non-psychoactive and non-addictive phytocannabinoid derived from Cannabis sativa L., has attracted increasing attention for its therapeutic potential in intestinal diseases. Accumulating evidence indicates that CBD exer…